Compare HCA Health Inc (HCA) vs MakeMyTrip Ltd (MMYT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs MakeMyTrip Ltd — how do they compare? HCA Health Inc trades at $371.46 (market cap $82.17B), while MakeMyTrip Ltd trades at $54.2 (market cap $5.05B). The key difference: HCA Health Inc is far larger — about 16.3× MakeMyTrip Ltd's market cap, and HCA Health Inc pays a 0.84% dividend while MakeMyTrip Ltd pays none. Which is the better fit depends on your goals.
| HCA | MMYT | |
|---|---|---|
Market Cap | $82.17B | $5.05B |
Sector | Health | Technology |
52-Week High | $545.13 | $103.21 |
52-Week Low | $334.32 | $36.30 |
Enterprise Value | $131.08B | $5.69B |
Dividend Yield | 0.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $370.74, down 0.12% on the day, with a bearish technical signal but strong fundamentals including consistent earnings beats and revenue growth to $75.6 billion in 2025. The stock faces headwinds from lowered 2026 guidance and negative news flow, but maintains a solid valuation with a P/E of 12.79 and positive analyst consensus.
The outlook is mixed: attractive valuation and operational strength support upside to the $469.40 price target, but near-term risks from payer mix shifts and legal investigations warrant caution. Long-term growth drivers include capacity expansion and medical advancements, though investor sentiment is currently pressured.
MakeMyTrip (MMYT) trades at $53.22, down 2.56% on the day, with a bullish technical signal and strong analyst support. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $0.25 exceeding expectations. Revenue for 2025 reached $978.34 million, though 2026 projections show a potential decline in net profit margin to 4.96%. Cash flow from operations remains healthy at $185.29 million, but a significant increase in liabilities is forecasted for 2026.
The outlook for MMYT is positive based on consistent earnings outperformance and a dominant market position in Indian online travel. Key risks include rising debt levels and travel demand volatility. With 72.73% of analysts rating it a Buy, the stock presents a growth opportunity, but investors must monitor execution against heightened financial leverage in the coming year.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About MakeMyTrip Ltd
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →
